Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.25 USD | -1.55% | +0.85% | +27.23% |
Apr. 30 | RBC Lifts Price Target on Avid Bioservices to $8 From $7, Keeps Outperform Rating | MT |
Apr. 29 | Transcript : Avid Bioservices, Inc., Q3 2024 Earnings Call, Apr 29, 2024 |
End-of-day quotes
Sector Biopharmaceuticals
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
532M | - | - | - | |||
88.91B | ||||||
41.25B | ||||||
31.99B | ||||||
24.73B | ||||||
15.54B |